Copyright
©The Author(s) 2025.
World J Gastroenterol. Apr 7, 2025; 31(13): 100566
Published online Apr 7, 2025. doi: 10.3748/wjg.v31.i13.100566
Published online Apr 7, 2025. doi: 10.3748/wjg.v31.i13.100566
Figure 6 Suppressor of cytokine signaling 2 inhibits regulatory T-cell activity.
A-C: In vitro induction of naïve T cells into Th1 A:, Th17 (B), and Th17 (C) subsets, with flow cytometry used to detect markers and quantify differentiation efficiency; D and E: Flow cytometry detection of Ki67 expression to evaluate the effect of suppressor of cytokine signaling 2 (SOCS2) overexpression on regulatory T-cell (Treg) cell proliferation; F and G: Flow cytometry detection of LAP expression to assess the impact of SOCS2 on Treg cell activity. cP < 0.001; SOCS2: Suppressor of cytokine signaling 2; Treg: Regulatory T-cell; IFN: Interferon; IL: Interleukin.
- Citation: Lan X, Zhang H, Chen ZY, Wang J, Zhang SC, Li Q, Ke JY, Wei W, Huang R, Tang X, Chen SP, Huang TT, Zhou YW. Suppressor of cytokine signaling 2 modulates regulatory T cell activity to suppress liver hepatocellular carcinoma growth and metastasis. World J Gastroenterol 2025; 31(13): 100566
- URL: https://www.wjgnet.com/1007-9327/full/v31/i13/100566.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i13.100566